Achiko AG

Pre-Annual General Meeting Information • Nov 25, 2022

News Details

Ad-hoc | 25 November 2022 18:10

Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022

Achiko AG / Key word(s): AGMEGM

25-Nov-2022 / 18:10 CET/CEST

Release of an ad hoc announcement pursuant to Art. 53 LR

The issuer is solely responsible for the content of this announcement.

---

Achiko AG issues a convocation notice to its shareholders for its Annual General Meeting on 20 December 2022

Zurich, 25 November 2022 : Achiko AG (SIX: ACHI; OTCQB:  ACHKF; ISIN CH0522213468) (“ A chiko ”, the “ Company ”) has issued a convocation notice to its shareholders for the Company’s Annual General Meeting taking place at 10:00 a.m. (CET) on 20 December 2022, in the offices of the Notary public Notariat Riesbach-Zurich, Kreuzstrasse 42, 8008 Zurich Zurich.

Due to the Covid-19 pandemic, this year’s Annual General Meeting will be held in accordance with art. 27 para. 1 letter b of the Covid-19-Ordinance 3 without physical presence of the shareholders. Shareholders may exercise their shareholders’ rights through the independent proxy only, as further set out in the invitation to the Annual General Meeting. The Board of Directors regrets not being able to welcome the shareholders to the Annual General Meeting this year and requests shareholders to make use of their ability to participate through the independent proxy.

Only shareholders that are registered with their personal information in the Company’s shareholder ledger may participate in the Annual General Meeting. Unregistered shareholders who wish to participate in the Annual General Meeting are kindly requested to contact the financial institution that holds the respective shares and to request their registration. The cut-off date for the participation in the Annual General Meeting is 5 December 2022. Only shareholders entered in the shareholder ledger with the right to vote until 5 December 2022 will be entitled to participate in the Annual General Meeting. For technical and legal reasons, shares cannot be registered directly through Achiko AG. Note that during the period from 5 December 2022 until and including 20 December 2022, no entries of shares will be made in the shareholder ledger.

The invitation to the Annual General Meeting of Achiko, containing the full agenda, the proposals of the Board of Directors as well as further information, is available as of today at https://www.achiko.com/financials .

ABOUT ACHIKO A G

Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; ww w.achiko.com ) is developing disruptive diagnostic solutions that put people first. The Company’s lead product, AptameX™, is a rapid, reliable Covid-19 test with a companion app, Teman Sehat™, offering a user-friendly digital health passport.  AptameX™ and Teman Sehat™ were launched in Indonesia in mid-2021 and AptameX™ received the CE Mark in the European Union in May 2022.

The AptameX™ DNA aptamer tests can be rapidly chemically synthesised, are cost-effective, easily scalable and have broad potential across multiple disease areas. Achiko aims to deliver fast, accurate and affordable diagnostic testing for a range of diseases in the rapidly evolving healthcare diagnostics field.

Headquartered in Zurich, Achiko has offices in Jakarta, and staff around the world.

M edia contacts:

ACHIKO AG

Investor Relations

E: ir@achiko.com

Switzerland & Global

Marcus Balogh

Farner Consulting Ltd

E: achiko@farner.ch

T: +41 44 266 67 67

Disclaimer

This communi c a tio n expressl y or i m plicitly c o nta i ns certa i n f or w ard-look i ng s tatem e nts c o ncernin g A chik o A G an d it s business . Suc h stat e ment s in v olv e certai n k n o w n a n d un k no w n risks, uncer t ainties a n d othe r f actors, w hi c h coul d cause the actua l results, f i n ancial c o nditi o n, per f or m ance or achi e vement s o f A chik o A G to be material l y di ff erent f rom any f u t ure results, pe r f ormance or achiev e ments expressed or implie d by such f or w ard-l o oki n g statem e nts. In consequence, no undue reliance should be placed on these forward-looking statements by investors. A chiko A G is providing this com m uni c ati o n as o f this date and d oe s not u nder t ake to u p d ate a n y f or w ard- l ooki n g stat e ments contain e d herein as a result o f ne w in f ormat i on , future eve n ts or o ther w ise

---

End of Inside Information

---

Language:	English
Company:	Achiko AG
	Tessinerplatz 7
	8002 Zurich
	Switzerland
E-mail:	ir@achiko.com
Internet:	https://www.achiko.com/
ISIN:	CH0522213468
Valor:	48788430
Listed:	SIX Swiss Exchange
EQS News ID:	1498101

End of Announcement	EQS News Service